BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30136751)

  • 21. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.
    Zhang P; Tang WM; Zhang H; Li YQ; Peng Y; Wang J; Liu GN; Huang XT; Zhao JJ; Li G; Li AM; Bai Y; Chen Y; Ren YX; Li GX; Wang YD; Liu SD; Wang JD
    Br J Cancer; 2017 Aug; 117(4):525-534. PubMed ID: 28632723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomes in ovarian cancer ascites promote epithelial-mesenchymal transition of ovarian cancer cells by delivery of miR-6780b-5p.
    Cai J; Gong L; Li G; Guo J; Yi X; Wang Z
    Cell Death Dis; 2021 Feb; 12(2):210. PubMed ID: 33627627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1.
    Gong C; Yang Z; Wu F; Han L; Liu Y; Gong W
    Oncol Rep; 2016 Oct; 36(4):2177-83. PubMed ID: 27499367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-16-5p inhibits chordoma cell proliferation, invasion and metastasis by targeting Smad3.
    Zhang H; Yang K; Ren T; Huang Y; Tang X; Guo W
    Cell Death Dis; 2018 Jun; 9(6):680. PubMed ID: 29880900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
    Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
    Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer.
    Sun Y; Hu L; Zheng H; Bagnoli M; Guo Y; Rupaimoole R; Rodriguez-Aguayo C; Lopez-Berestein G; Ji P; Chen K; Sood AK; Mezzanzanica D; Liu J; Sun B; Zhang W
    J Pathol; 2015 Jan; 235(1):25-36. PubMed ID: 25230372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
    Liu PL; Liu WL; Chang JM; Chen YH; Liu YP; Kuo HF; Hsieh CC; Ding YS; Chen WW; Chong IW
    PLoS One; 2017; 12(7):e0180844. PubMed ID: 28727734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2.
    Xing F; Song Z; He Y
    Biol Res; 2018 Nov; 51(1):50. PubMed ID: 30474570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gab2 promotes cancer stem cell like properties and metastatic growth of ovarian cancer via downregulation of miR-200c.
    Fang Z; Li T; Chen W; Wu D; Qin Y; Liu M; Wu G; He L; Li H; Gu H
    Exp Cell Res; 2019 Sep; 382(1):111462. PubMed ID: 31194976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
    Hu F; Min J; Cao X; Liu L; Ge Z; Hu J; Li X
    Biochem Biophys Res Commun; 2016 May; 474(1):35-42. PubMed ID: 27084453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
    Xu Q; Sun Q; Zhang J; Yu J; Chen W; Zhang Z
    Carcinogenesis; 2013 Mar; 34(3):539-49. PubMed ID: 23188671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activation of microRNA-520h-associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression.
    Zhang J; Liu W; Shen F; Ma X; Liu X; Tian F; Zeng W; Xi X; Lin Y
    Cell Death Dis; 2018 Aug; 9(9):884. PubMed ID: 30158641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
    Gao P; Wang S; Jing F; Zhan J; Wang Y
    Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
    Ping H; Guo L; Xi J; Wang D
    Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2.
    Zhang Z; Che X; Yang N; Bai Z; Wu Y; Zhao L; Pei H
    Biomed Pharmacother; 2017 Dec; 96():1341-1348. PubMed ID: 29196101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls.
    Eriksson J; Le Joncour V; Jahkola T; Juteau S; Laakkonen P; Saksela O; Hölttä E
    Mol Oncol; 2020 Apr; 14(4):742-762. PubMed ID: 32053263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition.
    Tang Y; Wang Y; Chen Q; Qiu N; Zhao Y; You X
    Int J Clin Exp Pathol; 2015; 8(9):11224-9. PubMed ID: 26617846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.